How Is AI Used in Healthcare and Future Trends
One of the top searches in medicine today is how is AI used in healthcare and future trends, and as expected, AI has advanced into clinical tools with regulatory approval speedier than just about any other industry. Since 1995, the U.S. The Food and Drug Administration has approved over 1,400 medical devices with AI and machine learning capabilities, including 331 devices approved in 2025 the highest number ever for the FDA.
This guide explores the tangible clinical outcomes that AI is achieving in healthcare today, supported by regulatory insights and peer-reviewed clinical trials, and the evolution of AI healthcare solutions that are shaping the future, not just the future, but the future as revealed in the data.
AI in Healthcare: What is it?
AI in healthcare is the term used for the application of artificial intelligence (AI) machine learning models and algorithms within clinical and administrative functions, such as reading a medical scan or predicting which patients will be readmitted. There are two main categories of AI applications in healthcare: narrow, task-specific AI models, which are designed for specific tasks such as detecting tumors, and broader AI systems that can be used in clinical decision-making for a wider variety of tasks.
The majority of AI healthcare solutions that have been approved by the FDA are in the first category. The clinical evidence and regulatory pathway is most advanced in the context of radiology, hence the share of these devices is the highest. This is also where the adoption of Artificial Intelligence in healthcare has the longest history as imaging data was standardized and digitized long before most other types of healthcare data.
AI in Hospitals: Where is it being deployed?
Currently, AI applications within the healthcare sector are limited to specific high-volume, high-data fields such as radiology. Large quantities of standardized image data in diagnostic imaging, cardiology, and pathology are already the foundation for large-scale training and testing of early AI models, leading the way.
Administrative applications are also making significant strides, although they don't receive the same level of attention. In the healthcare sector today, automated clinical documentation, scheduling optimization, and revenue cycle management are just a few examples of how AI is being used in hospitals with workflows that have less clinical risk but more operational time savings. This time-trend in the broader application of AI technology in healthcare where isolated successes are achieved in a narrow range of well-defined workflows is exactly reflected by the diagnostic imaging data above.
The Data Behind AI in Medical Industry Adoption
The figures behind the use of AI in the medical sector are also one of the most easily quantifiable of any and all areas of application for AI, as medical devices have a formal regulatory clearance process that provides an obvious paper trail.
| Finding | Source |
| More than 1,400 AI/ML-enabled medical devices authorized since 1995, with 331 authorized in 2025 alone the most in agency history | U.S. Food and Drug Administration, AI/ML-Enabled Medical Devices List |
| Radiology AI systems reduce diagnostic errors by and cut interpretation time | PMC |
| AI-supported breast cancer screening increased cancer detection by 20% while cutting radiologist workload by 44% | MASAI randomized controlled trial, 105,934 women |
| AI achieved 80.5% sensitivity in mammography screening, versus 73.8% for radiologists alone | MASAI randomized controlled trial |
The result is especially remarkable because it was not merely a laboratory test outcome, but rather was a real-world, randomized controlled trial conducted within real screening programs involving more than 100,000 participants; the evidence base that regulators and clinicians rely on. It is also one of the most obvious trends in healthcare AI to be aware of, as it provides evidence on a scale that most single-institution studies can't match.
AI for Patient Care: Benefits Already in Practice
The potential for AI to improve care delivery is focused in a few well-defined areas, with supporting regulatory or clinical trial evidence.
- Faster, More Accurate Diagnostic Imaging
According to McKinsey's research, the AI systems in radiology minimize diagnostic errors by 23% and decrease interpretation times by 35%, which is a direct benefit to both accuracy and speed in one of the highest volume diagnostic workflows in medicine.
- Higher Cancer Detection, Less Clinician Workload
The MASAI randomized controlled trial showed that using AI for breast cancer screening not only improved detection rate by 20%, but it also reduced radiologist workload by 44% which is a rare instance where an AI tool in the clinic improved an outcome and reduced staff burden simultaneously.
- Predictive Risk Identification
In the healthcare industry, machine learning can be applied to identify patients with potential complications before they occur, or to flag those likely to be readmitted after a visit to an emergency room, affording care providers a chance to prevent those issues from arising at a later stage in a reactive workflow. This predictive use case is growing at a more rapid rate than diagnostic imaging in terms of absolute deployment, although it is not as well known.
- Reduced Administrative Burden
One of the most frequently cited causes of clinician burnout that doesn't require a change to clinical protocols is to free up some of the time spent on manual data entry thanks to the help of AI-assisted documentation and scheduling tools. It's an emerging type of machine learning in healthcare that provides tangible time savings without impacting any clinical decision.
The Challenges Healing AI is facing is what remains to be conquered.
Each of these advantages is accompanied by a challenge that health care organizations are striving to address.
1. Regulatory Complexity
Despite the over 1400 devices being cleared, however, FDA clearance is a long and research-heavy process and many AI-driven healthcare solutions are still at earlier stages of development or trials, hence not making it to clinical deployment in the near future. This degree of regulation is one of the reasons the result of the MASAI trial is so significant. Randomized evidence is becoming the clinical benchmark against which the success of AI is increasingly being measured.
2. Workflow Integration
While an AI system that works well in a laboratory setting may not work well in a hospital setting because it doesn't fit the hospital's existing electronic health record and clinical workflow, there is a disconnect between the accuracy it performs in a laboratory study and the accuracy it performs in the real world. The engineering investment needed to close that gap is often as large as building the model, as the integration layer will determine whether the clinical user will actually see the model when needed.
3. Bias and Generalizability
AI models that are trained on non-representative patient data may perform less well for populations that are underrepresented, and diverse training data and performance monitoring are a clinical safety need, rather than simply a fairness concern.
4. Clinician Trust and Adoption.
Even a highly validated tool must first be embraced by clinicians for it to be utilized as intended; a validated tool with high benchmark accuracy will need to be adopted by the clinician in a time-limited clinical situation.
The Future of AI in Healthcare
Currently, as per the regulations and clinical trials, several trends are emerging that indicate the future direction of AI in healthcare.
1. Continued Growth in FDA-Authorized Devices
The regulatory process for authorizing new AI devices has not abated; in fact, year 2025 alone saw 331 new authorizations, with the number of clinically validated devices projected to continue to grow in the coming years. That alone makes AI in medical industry planning a priority for most companies in the field, not a longer-term enterprise.
2. Expansion Beyond Radiology
Cardiology, pathology and other data-rich specialties are on the same path as radiology: the accumulation of standardized data, metrics for evaluating success, and an increasing body of evidence.
3. Evidence-Based Deployment Over Broad Claims
The best recent evidence such as that of the MASAI trial uses a randomized, large trial instead of vendor reported benchmarks, which is increasingly the standard expected for the clinical claims of AI in general.
AI/ML Development Services in Healthcare AI Solutions
The best way to implement an AI/ML solution in a health care setting is to build it with the healthcare lens on, rather than just adding an AI feature to a system: that means having the right data quality and integration concerns addressed up front, and being cognizant of the regulations governing healthcare.
When considering a partner for this work, businesses should inquire directly about how the provider manages compliance with data privacy requirements, as well as how it integrates the workflow into existing clinical systems, two challenges that most often put a validated pilot to the test and keep it from becoming a tool used by clinicians.
How Chirpn helps in AI in Healthcare Projects?
Chirpn IT Solutions have experience in the healthcare sector, where they're using AI/ML development. Chirpn's work on AI/ML development was no exception, as it included the development of AI-powered systems for Parentis Health, an India-based healthcare organization, that took place in a standard 45-60 day delivery schedule and leveraged AutoPATH, Chirpn's AI-orchestrated development framework, which requires the same data governance and integration discipline as any AI in medical industry project, to deliver.
Chirpn, a Google Certified Cloud Partner with access to Google Vertex AI and Google Agent Assist, provides enterprise-class AI infrastructure for health care organizations that demand a compliant, well-integrated AI deployment instead of one of the many off-the-shelf tools simply put together to meet post hoc clinical needs.
Looking to discuss how AI can help your healthcare organization? Talk to Chirpn.
Conclusion
How is AI used in healthcare and future trends means taking a defined approach with an evaluation process; it's about the applications that have been tested, not just sweeping claims. More than 1,400 FDA approved devices and a 20% reduction in the rate of cancer detection in a study of 105,934 people are not marketing statistics, they are regulatory and clinical trial data that has taken years to build.
The organizations that are getting the best outcomes with AI in healthcare have made it a point to ensure from the beginning of designing their AI implementation that it must be compliant with regulations, seamlessly integrated into the workflow, and validated for clinical use. That, more than any single algorithm, is the key to making a viable and effective AI model a healthcare AI trend that can translate to better patient care not the next failed pilot program that never gets to the patients it was designed to assist.
Frequently Asked Questions
What are the current applications of AI in healthcare?
Today, the applications of AI in healthcare are mainly focused on diagnostic imaging, where the use of AI in radiology can lower diagnostic errors by 23% and interpretation time by 35% according to McKinsey. It's also being applied to predictive risk identification, administrative automation such as clinical documentation and now in cancer screening, in which a large randomized trial showed AI-supported breast cancer screening increased detection by 20%.
How many AI medical devices has the FDA approved?
As of 2019, the FDA has approved over 1,400 medical devices with AI, or machine learning systems, since 1995, according to the FDA's list of AI/ML-Enabled Medical Devices. Of the 331 devices authorized in 2025 alone, the largest number of them 117 was for the use of radiology.
What are some of the most significant challenges of AI in health care?
The most important barriers include regulatory complexity due to the FDA clearance process, workflow integration with current EHR systems, bias and generalizability of tools across patient populations, and clinician trust and use, even for well-validated tools.
Is AI more precise than the doctors at diagnosis?
In limited, specific, and clearly defined tasks, AI has been shown to be as effective as or better than human performance in controlled trials. AI sensitivity reached 80.5% in the mammography screening task vs 73.8% for the radiologists alone in the MASAI trial. This is for narrow, well-defined tasks, not medical diagnosis in general, and strongest deployments will be those that support a clinician rather than supplant them.
What lies ahead for AI in healthcare?
Given the regulatory information available today, the trajectory of FDA cleared devices in the healthcare space is becoming more exciting than radiology, extending into cardiology and pathology, and more evidence-based than relying just on vendor-reported benchmarks.
